Purpose To develop and evaluate a tool for the qualitative pre-diction of human oral bioavailability (Fhuman) from animal oral bioavailability (Fanimal) data employing ROC analysis and to identify the optimal thresholds for such predictions. Methods A dataset of 184 compounds with known Fhuman and Fanimal in at least one species (mouse, rat, dog and non-human primates (NHP)) was employed. A binary classification model for Fhuman was built by setting a threshold for high/low Fhuman at 50%. The thresholds for high/low Fanimal were varied from 0 to 100 to generate the ROC curves. Optimal thresholds were derived from ‘cost analysis ’ and the outcomes with respect to false negative and false positive predictions were analyzed against the BDDCS c...
Orally administered drugs must overcome several barriers before reaching their target site. Such bar...
Purpose It has been increasingly recognised that there is a need to reduce costly drug development d...
Knowledge of human concentration–time profiles from animal data can be useful during early drug deve...
Oral bioavailability (F) is an essential determinant for the systemic exposure and dosing regimens o...
AbstractOral bioavailability is a key consideration in development of drug products, and the use of ...
<p>The performance of machine learning algorithms for the prediction of oral bioavailability (panel ...
prediction of oral bioavailability (%F) based on physiochemical properties are highly needed. Altho...
Poor oral bioavailability is an important parameter accounting for the failure of the drug candidate...
(a) ROC curves of the performance of the human liver enhancer classifier applied to the human (Hsap)...
A critically evaluated database of human oral bioavailability for 768 chemical compounds is describe...
(a) ROC curves for classification of liver enhancers vs. the genomic background in six diverse mamma...
This review discusses evolutionary and adaptive methods for predicting oral bioavailability (OB) fro...
These days, there is a lot of emphasis on the prediction of human clearance (CL) from a single speci...
Oral bioavailability (%F) is a key factor that determines the fate of a new drug in clinical trials....
The authors present a comprehensive analysis on the estimation of volume of distribution at steady s...
Orally administered drugs must overcome several barriers before reaching their target site. Such bar...
Purpose It has been increasingly recognised that there is a need to reduce costly drug development d...
Knowledge of human concentration–time profiles from animal data can be useful during early drug deve...
Oral bioavailability (F) is an essential determinant for the systemic exposure and dosing regimens o...
AbstractOral bioavailability is a key consideration in development of drug products, and the use of ...
<p>The performance of machine learning algorithms for the prediction of oral bioavailability (panel ...
prediction of oral bioavailability (%F) based on physiochemical properties are highly needed. Altho...
Poor oral bioavailability is an important parameter accounting for the failure of the drug candidate...
(a) ROC curves of the performance of the human liver enhancer classifier applied to the human (Hsap)...
A critically evaluated database of human oral bioavailability for 768 chemical compounds is describe...
(a) ROC curves for classification of liver enhancers vs. the genomic background in six diverse mamma...
This review discusses evolutionary and adaptive methods for predicting oral bioavailability (OB) fro...
These days, there is a lot of emphasis on the prediction of human clearance (CL) from a single speci...
Oral bioavailability (%F) is a key factor that determines the fate of a new drug in clinical trials....
The authors present a comprehensive analysis on the estimation of volume of distribution at steady s...
Orally administered drugs must overcome several barriers before reaching their target site. Such bar...
Purpose It has been increasingly recognised that there is a need to reduce costly drug development d...
Knowledge of human concentration–time profiles from animal data can be useful during early drug deve...